Search
for
Sort by
Research 151–180 of 1000+
- Niosomes as Vesicular Nanocarriers in Cosmetics: Characterisation, Development and Efficacy
- Evaluation of efficacy, safety, and reversibility of combination regimen of cyproterone acetate and testosterone buciclate in bonnet monkey
- Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Pectin Nanoparticle-Loaded Soft Coral Nephthea sp. Extract as In Situ Gel Enhances Chronic Wound Healing: In Vitro, In Vivo, and In Silico Studies
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- The pharmacology of methotrexate
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Methotrexate in dermatology
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Prospective, Open-Label, Multi-Centre, Randomized Study to Compare the Effectiveness, Safety, and Tolerability of Lulican™ Shampoo Versus Ketoconazole Shampoo in Indian Adult Patients With Mild to Moderate Scalp Seborrheic Dermatitis (LEAD Study)
- Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Evaluation of Herbs Nutraceutical Products Potential for Hair Growth Promotion: Formulation on Aspects for Polyherbal Hair Oil
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Pharmacological Effects of Natural Compounds Extracted from Urtica dioica Evaluated by in Silico and Experimental Methods
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- 4-O-Methylhonokiol: A lesser-known neolignan from Magnolia species with diverse and promising pharmacological properties
- Teriflunomide in multiple sclerosis: an update
- Guidelines for the Use of Acitretin in Psoriasis